Defibrillator-Heart Pump: An Implantable Ventricular Assist Device With Integrated Defibrillator Component—The First In Vitro Testing

Anas Aboud; Kai Liebing; Charlie Abraham; Jan Christian Reil; Yara Turkistani; Thomas Eitz; Stephan Ensminger; Jan Gummert; Michiel Morshuis

doi:10.1177/1553350619862994

Defibrillator-Heart Pump: An Implantable Ventricular Assist Device With Integrated Defibrillator Component—The First In Vitro Testing

Anas Aboud^*, Kai Liebing, Charlie Abraham, Jan Christian Reil, Yara Turkistani, Thomas Eitz, Stephan Ensminger, Jan Gummert, Michiel Morshuis

^*Corresponding author for this work

Abstract

Left ventricular assist devices (LVADs) are an important therapeutic option for patients with end-stage heart failure waiting for heart transplantation or in older patients as definite therapy for heart failure. Interestingly, about 62% of patients receiving LVADs do not have an automatic implantable cardioverter-defibrillator (AICD) at the time of implantation, although these patients have increased risk of being confronted with dangerous arrhythmia. Therefore, an LVAD system including AICD function is a reasonable alternative for such heart failure patients thereby avoiding a second surgical intervention for AICD implantation. In this article, a newly developed system including LVAD and AICD function is introduced, and we also report its first in vitro testing.

Original language	English
Journal	Surgical Innovation
Volume	26
Issue number	6
Pages (from-to)	720-724
Number of pages	5
ISSN	1553-3506
DOIs	https://doi.org/10.1177/1553350619862994
Publication status	Published - 01.12.2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1177/1553350619862994

Cite this

@article{2aaaa453e3394cb5816a3fa6df0d700b,

title = "Defibrillator-Heart Pump: An Implantable Ventricular Assist Device With Integrated Defibrillator Component—The First In Vitro Testing",

abstract = "Left ventricular assist devices (LVADs) are an important therapeutic option for patients with end-stage heart failure waiting for heart transplantation or in older patients as definite therapy for heart failure. Interestingly, about 62\% of patients receiving LVADs do not have an automatic implantable cardioverter-defibrillator (AICD) at the time of implantation, although these patients have increased risk of being confronted with dangerous arrhythmia. Therefore, an LVAD system including AICD function is a reasonable alternative for such heart failure patients thereby avoiding a second surgical intervention for AICD implantation. In this article, a newly developed system including LVAD and AICD function is introduced, and we also report its first in vitro testing.",

author = "Anas Aboud and Kai Liebing and Charlie Abraham and Reil, \{Jan Christian\} and Yara Turkistani and Thomas Eitz and Stephan Ensminger and Jan Gummert and Michiel Morshuis",

year = "2019",

month = dec,

day = "1",

doi = "10.1177/1553350619862994",

language = "English",

volume = "26",

pages = "720--724",

journal = "Surgical Innovation",

issn = "1553-3506",

publisher = "SAGE Publications Inc.",

number = "6",

}

TY - JOUR

T1 - Defibrillator-Heart Pump: An Implantable Ventricular Assist Device With Integrated Defibrillator Component—The First In Vitro Testing

AU - Aboud, Anas

AU - Liebing, Kai

AU - Abraham, Charlie

AU - Reil, Jan Christian

AU - Turkistani, Yara

AU - Eitz, Thomas

AU - Ensminger, Stephan

AU - Gummert, Jan

AU - Morshuis, Michiel

PY - 2019/12/1

Y1 - 2019/12/1

N2 - Left ventricular assist devices (LVADs) are an important therapeutic option for patients with end-stage heart failure waiting for heart transplantation or in older patients as definite therapy for heart failure. Interestingly, about 62% of patients receiving LVADs do not have an automatic implantable cardioverter-defibrillator (AICD) at the time of implantation, although these patients have increased risk of being confronted with dangerous arrhythmia. Therefore, an LVAD system including AICD function is a reasonable alternative for such heart failure patients thereby avoiding a second surgical intervention for AICD implantation. In this article, a newly developed system including LVAD and AICD function is introduced, and we also report its first in vitro testing.

AB - Left ventricular assist devices (LVADs) are an important therapeutic option for patients with end-stage heart failure waiting for heart transplantation or in older patients as definite therapy for heart failure. Interestingly, about 62% of patients receiving LVADs do not have an automatic implantable cardioverter-defibrillator (AICD) at the time of implantation, although these patients have increased risk of being confronted with dangerous arrhythmia. Therefore, an LVAD system including AICD function is a reasonable alternative for such heart failure patients thereby avoiding a second surgical intervention for AICD implantation. In this article, a newly developed system including LVAD and AICD function is introduced, and we also report its first in vitro testing.

UR - https://www.scopus.com/pages/publications/85070311696

U2 - 10.1177/1553350619862994

DO - 10.1177/1553350619862994

M3 - Journal articles

C2 - 31354072

AN - SCOPUS:85070311696

SN - 1553-3506

VL - 26

SP - 720

EP - 724

JO - Surgical Innovation

JF - Surgical Innovation

IS - 6

ER -

Defibrillator-Heart Pump: An Implantable Ventricular Assist Device With Integrated Defibrillator Component—The First In Vitro Testing

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this